Avenue Therapeutics Shares Outstanding 2016-2020 | ATXI

Avenue Therapeutics shares outstanding from 2016 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Avenue Therapeutics Annual Shares Outstanding
(Millions of Shares)
2019 16
2018 10
2017 7
2016 3
2015
Avenue Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2020-03-31 16
2019-12-31 16
2019-09-30 16
2019-06-30 16
2019-03-31 14
2018-12-31 10
2018-09-30 10
2018-06-30 10
2018-03-31 10
2017-12-31 7
2017-09-30 10
2017-06-30 3
2017-03-31 3
2016-12-31
2016-09-30 3
2016-06-30 3
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.191B $0.000B
Avenue Therapeutics, Inc. is a specialty pharmaceutical company. It acquires, licenses, develops and commercializes products principally for use in the acute/intensive care hospital setting. Avenue Therapeutics, Inc. is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.195B 38.13
Takeda Pharmaceutical (TAK) Japan $60.564B 10.61
Astellas Pharma (ALPMY) Japan $33.885B 16.92
Eisai (ESALY) Japan $23.619B 44.00
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $14.734B 19.32
Grifols, S.A (GRFS) Spain $13.834B 17.20
Catalent (CTLT) United States $12.084B 46.71
Neurocrine Biosciences (NBIX) United States $11.457B 52.95
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.035B 42.72
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.623B 0.00
Orion OYJ (ORINY) Finland $7.297B 32.70
IPSEN SA ADR (IPSEY) France $6.744B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.522B 10.44
United Therapeutics (UTHR) United States $5.416B 10.26
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Hypermarcas (HYPMY) Brazil $4.147B 12.62
Evotec AG (EVTCY) Germany $4.076B 65.73
Nektar Therapeutics (NKTR) United States $3.880B 0.00
ChemoCentryx (CCXI) United States $3.832B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.335B 364.11
PTC Therapeutics (PTCT) United States $3.204B 0.00
FibroGen (FGEN) United States $3.022B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.629B 10.81
Cronos Group (CRON) Canada $2.243B 64.30
Pacira BioSciences (PCRX) United States $1.836B 37.57
Sage Therapeutics (SAGE) United States $1.807B 0.00
Xencor (XNCR) United States $1.767B 0.00
USANA Health Sciences (USNA) United States $1.762B 18.07
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.737B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.674B 0.00
Heron Therapeutics (HRTX) United States $1.673B 0.00
Zogenix (ZGNX) United States $1.669B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.667B 12.76
Corcept Therapeutics (CORT) United States $1.641B 16.27
Akebia Therapeutics (AKBA) United States $1.473B 0.00
Portola Pharmaceuticals (PTLA) United States $1.409B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.407B 15.16
Karyopharm Therapeutics (KPTI) United States $1.322B 0.00
Tilray (TLRY) Canada $1.249B 0.00
Translate Bio (TBIO) United States $1.249B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.177B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.008B 45.01
Indivior (INVVY) United States $0.916B 11.36
ImmunoGen (IMGN) United States $0.895B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.834B 0.00
Endo (ENDP) Ireland $0.829B 1.28
Molecular Templates (MTEM) United States $0.726B 0.00
Aerie Pharmaceuticals (AERI) United States $0.704B 0.00
Collegium Pharmaceutical (COLL) United States $0.696B 0.00
Ardelyx (ARDX) United States $0.651B 0.00
Trillium Therapeutics (TRIL) Canada $0.641B 0.00
Radius Health (RDUS) United States $0.583B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.519B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.511B 0.00
Innate Pharma SA (IPHYF) France $0.495B 0.00
DURECT (DRRX) United States $0.478B 0.00
Siga Technologies (SIGA) United States $0.477B 0.00
Flexion Therapeutics (FLXN) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 11.25
Harpoon Therapeutics (HARP) United States $0.457B 0.00
Organogenesis Holdings (ORGO) United States $0.444B 0.00
MEI Pharma (MEIP) United States $0.440B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 16.73
Calithera Biosciences (CALA) United States $0.402B 0.00
Ocular Therapeutix (OCUL) United States $0.377B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.332B 0.00
TherapeuticsMD (TXMD) United States $0.310B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Lannett Co Inc (LCI) United States $0.302B 6.63
Concert Pharmaceuticals (CNCE) United States $0.294B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
CASI Pharmaceuticals (CASI) United States $0.279B 0.00
Redhill Biopharma (RDHL) Israel $0.252B 0.00
Rafael Holdings (RFL) United States $0.242B 0.00
OptiNose (OPTN) United States $0.227B 0.00
VAXART, INC (VXRT) United States $0.217B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
PROFOUND MEDICL (PROF) Canada $0.193B 0.00
Jounce Therapeutics (JNCE) United States $0.188B 4.49
Taiwan Liposome (TLC) Taiwan $0.187B 0.00
IMV INC (IMV) Canada $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 24.00
Xeris Pharmaceuticals (XERS) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
Altimmune (ALT) United States $0.139B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.120B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.112B 0.00
Recro Pharma (REPH) United States $0.109B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.104B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Sundial Growers (SNDL) Canada $0.089B 0.00
Otonomy (OTIC) United States $0.085B 0.00
Onconova Therapeutics (ONTX) United States $0.085B 0.00
CV Sciences (CVSI) United States $0.084B 0.00
CTI BioPharma (CTIC) United States $0.082B 0.00
SCYNEXIS (SCYX) United States $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.081B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
Nivalis Therapeutics (ALPN) United States $0.074B 0.00
Heat Biologics (HTBX) United States $0.068B 0.00
Biomerica (BMRA) United States $0.062B 0.00
Aclaris Therapeutics (ACRS) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
MediWound (MDWD) Israel $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.00
GTx (ONCT) United States $0.050B 0.00
IsoRay (ISR) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 102.73
Natural Alternatives (NAII) United States $0.046B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
Lipocine (LPCN) United States $0.043B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Addex Therapeutics (ADXN) Switzerland $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
AgeX Therapeutics (AGE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 7.28
Neos Therapeutics (NEOS) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Novan (NOVN) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.026B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00